Hair4U (Minoxidil) Solution
What is Hair4U (Minoxidil) Solution used for?
Hair4U 2% (Minoxidil) is a synthetic drug used to treat the initial stages of hair loss and androgenic baldness.
The mechanism of action by which minoxidil enhances hair growth is not fully understood.
Minoxidil contains nitrogen oxide - a chemical functional group of nitrogen, so it can have properties of nitrogen oxide receptor agonists.
In addition, minoxidil due to action on potassium channels causes hyperpolarization of cell membranes. Minoxidil also stimulates the enzyme cyclooxygenase-2, which directly promotes the expression of the VEGF gene, and indirectly contributes to its expression by opening calcium channels and increasing the amount of calcium in cells.
Minoxidil also stimulates the proliferation of the cells of the hair follicles and keratinocytes.
Minoxidil is less effective in larger hair loss areas, and, moreover, its effectiveness is mainly recorded in young men with hair loss of less than 5 years. Minoxidil is more effective in hair loss in the parietal region. The effectiveness of minoxidil is lower in the presence of inflammation in the area of ??hair follicles. The effectiveness of minoxidil becomes noticeable in its long-term use (from 3 months to a year).
How should I use Hair4U (Minoxidil) Solution?
Always follow your doctor`s instructions when using Hair4U 2% (Minoxidil) to get the safest and most effective results from treatment.
Hair4U 2% (Minoxidil) is recommended twice a day for the treatment of baldness. For a visible effect, prolonged use of the drug is required, the first results of which can be assessed in 2-3 months.
What are the side effects of Hair4U (Minoxidil) Solution?
The use of Hair4U 2% (Minoxidil) may cause side effects in some patients including:
Contact your doctor immediately if you experience any serious or worrying symptoms.
Hair4U 2% (Minoxidil) is for external use only. Avoid contact with eyes and internal use.
Use during pregnancy and lactation: Contraindicated in pregnancy (adequate and strictly controlled studies in humans have not been conducted). At the time of treatment should stop breastfeeding.